Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Experimental rabies vaccines for humans.

McGettigan JP.

Expert Rev Vaccines. 2010 Oct;9(10):1177-86. doi: 10.1586/erv.10.105. Review.

2.

Inactivated or live-attenuated bivalent vaccines that confer protection against rabies and Ebola viruses.

Blaney JE, Wirblich C, Papaneri AB, Johnson RF, Myers CJ, Juelich TL, Holbrook MR, Freiberg AN, Bernbaum JG, Jahrling PB, Paragas J, Schnell MJ.

J Virol. 2011 Oct;85(20):10605-16. doi: 10.1128/JVI.00558-11. Epub 2011 Aug 17.

3.

Efficiency of live attenuated and inactivated rabies viruses in prophylactic and post exposure vaccination against the street virus strain.

Huang F, Ahmad W, Duan M, Liu Z, Guan Z, Zhang M, Qiao B, Li Y, Song Y, Song Y, Chen Y, Amjad Ali M.

Acta Virol. 2015 Jun;59(2):117-24.

PMID:
26104328
4.

Effect of heterogeneity of rabies virus strain and challenge route on efficacy of inactivated rabies vaccines in mice.

Wunderli PS, Dreesen DW, Miller TJ, Baer GM.

Am J Vet Res. 2003 Apr;64(4):499-505.

PMID:
12693543
5.

Generation of a recombinant rabies Flury LEP virus carrying an additional G gene creates an improved seed virus for inactivated vaccine production.

Tao L, Ge J, Wang X, Wen Z, Zhai H, Hua T, Zhao B, Kong D, Yang C, Bu Z.

Virol J. 2011 Sep 25;8:454. doi: 10.1186/1743-422X-8-454.

6.

Protection of non-human primates against rabies with an adenovirus recombinant vaccine.

Xiang ZQ, Greenberg L, Ertl HC, Rupprecht CE.

Virology. 2014 Feb;450-451:243-9. doi: 10.1016/j.virol.2013.12.029. Epub 2014 Jan 9.

7.

Preexposure efficacy of a novel combination DNA and inactivated rabies virus vaccine.

Biswas S, Reddy GS, Srinivasan VA, Rangarajan PN.

Hum Gene Ther. 2001 Oct 10;12(15):1917-22.

PMID:
11589833
8.

Genetic characterisation of the rabies virus vaccine strains used for oral immunization of foxes in Poland to estimate the effectiveness of vaccination.

Orłowska A, Żmudziński JF.

Arch Virol. 2015 Feb;160(2):509-15. doi: 10.1007/s00705-014-2269-y. Epub 2014 Nov 19.

9.
10.

Three-year duration of immunity in cats vaccinated with a canarypox-vectored recombinant rabies virus vaccine.

Jas D, Coupier C, Toulemonde CE, Guigal PM, Poulet H.

Vaccine. 2012 Nov 19;30(49):6991-6. doi: 10.1016/j.vaccine.2012.09.068. Epub 2012 Oct 8.

PMID:
23059358
11.

Canine adenoviruses elicit both humoral and cell-mediated immune responses against rabies following immunisation of sheep.

Bouet-Cararo C, Contreras V, Fournier A, Jallet C, Guibert JM, Dubois E, Thiery R, Bréard E, Tordo N, Richardson J, Schwartz-Cornil I, Zientara S, Klonjkowski B.

Vaccine. 2011 Feb 1;29(6):1304-10. doi: 10.1016/j.vaccine.2010.11.068. Epub 2010 Dec 4.

PMID:
21134446
12.

Immunogenicity study of abbreviated rabies preexposure vaccination schedules.

Khawplod P, Wilde H, Benjavongkulchai M, Sriaroon C, Chomchey P.

J Travel Med. 2007 May-Jun;14(3):173-6.

13.

An inactivated recombinant rabies CVS-11 virus expressing two copies of the glycoprotein elicits a higher level of neutralizing antibodies and provides better protection in mice.

Xue XH, Zheng XX, Wang HL, Ma JZ, Li L, Gai WW, Wang TC, Yang ST, Xia XZ.

Virus Genes. 2014 Jun;48(3):411-20. doi: 10.1007/s11262-014-1049-9. Epub 2014 Feb 18.

PMID:
24535572
14.
15.

Rabies virus pathogenesis in relationship to intervention with inactivated and attenuated rabies vaccines.

Franka R, Wu X, Jackson FR, Velasco-Villa A, Palmer DP, Henderson H, Hayat W, Green DB, Blanton JD, Greenberg L, Rupprecht CE.

Vaccine. 2009 Nov 27;27(51):7149-55. doi: 10.1016/j.vaccine.2009.09.034.

PMID:
19925945
16.

Intradermal rabies vaccination: the evolution and future of pre- and post-exposure prophylaxis.

Warrell MJ.

Curr Top Microbiol Immunol. 2012;351:139-57. doi: 10.1007/82_2010_121. Review.

PMID:
21267707
17.

Target and non-target effects of a recombinant vaccinia-rabies virus developed for fox vaccination against rabies.

Pastoret PP, Brochier B, Boulanger D.

Dev Biol Stand. 1995;84:183-93. Review. No abstract available.

PMID:
7796953
18.

Parainfluenza virus 5 expressing the G protein of rabies virus protects mice after rabies virus infection.

Huang Y, Chen Z, Huang J, Fu Z, He B.

J Virol. 2015 Mar;89(6):3427-9. doi: 10.1128/JVI.03656-14. Epub 2014 Dec 31.

19.

Antibody response to an anti-rabies vaccine in a dog population under field conditions in Bolivia.

Suzuki K, González ET, Ascarrunz G, Loza A, Pérez M, Ruiz G, Rojas L, Mancilla K, Pereira JA, Guzman JA, Pecoraro MR.

Zoonoses Public Health. 2008 Oct;55(8-10):414-20. doi: 10.1111/j.1863-2378.2008.01126.x. Epub 2008 Apr 9.

PMID:
18399941
20.

[Oral vaccination in the control of feral rabies].

Biocca E, Bellani L.

Parassitologia. 1988 Jan-Apr;30(1):3-12. Italian.

PMID:
3268770

Supplemental Content

Support Center